Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives

Journal of Clinical Pathology

Volumn 58, Issue 1, 2005, Pages 90-92

  Prasad, M L ^a   Velickovic, M ^a   Weston, S A ^a   Benson, E M ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND;

ADULT; ARTICLE; CD40L GENE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC HETEROGENEITY; GENETIC SCREENING; HETEROZYGOTE; HUMAN; HYPERIMMUNOGLOBULINEMIA M; IMMUNE DEFICIENCY; MOLECULAR GENETICS; MULTIGENE FAMILY; NONSENSE MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; X CHROMOSOME LINKAGE;

ADOLESCENT; ADULT; CD40 LIGAND; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC DISEASES, X-LINKED; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN M; INFANT; MALE; MUTATION;

EID: 11244339738     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.019711     Document Type: Article

References (14)

1. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiency. Clin Immunol 1999;93:190-7.
2. Hollenbaugh D, Grosmaire LS, Kullas CD, et al. The human T cell antigen gp39, a member of the TNF family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992;11:4313-21.
3. Gilmour KC, Walshe D, Heath S, et al. Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM. J Clin Pathol 2003;56:256-62.
4. Shimadzu M, Nunoi H, Terasaki H, et al. Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome. Biochim Biophys Acta 1995;1260:67-72.
5. Notarangelo LD, Peitsch MC. CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 1996;17:511-16.
6. Seyama K, Nonoyama S, Gangsaas I, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 1998;92:2421-34.
7. Macchi P, Villa A, Strina D, et al. Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome. Am J Hum Genet 1995;56:898-906.
8. Lin Q, Rohrer J, Allen C, et al. A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome. J Clin Invest 1996;97:196-201.
9. Katz F, Hinshelwood S, Rutland P, et al. Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome. Hum Mutat 1996;8:223-8.
10. den Dunnen JT, Antonarakis SE. Mutations nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000;15:7-12.
11. Seyama K, Kira S, Ishidoh K, et al. Genomic structure and PCR-SSCP analysis of the human CD40 ligand gene: its application to prenatal screening for X-linked hyper-IgM syndrome. Hum Genet 1996;97:180-5.
12. Notarangelo LD, Hayward AR. X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol 2000;120:399-405.
13. Garber E, Su L, Ehrenfels B, et al. CD154 variants associated with hyper IgM syndrome can form oligomers and trigger CD40-mediated signals. J Biol Chem 1999;274:33545-50.
14. Jones AM, Gaspar HB. Immunogenetics: changing the face of immunodeficiency. J Clin Pathol 2000;53:60-3.